15 Jan 2016 --- Bacteria that live in and on our bodies have been said to outnumber the number of human cells by 10 to 1 – although recent research shows that in fact we may be similar in numbers to them, with the ratio being closer to 1:1. There is an increased awareness that these bacteria, called the microbiome, play a crucial role in human health and diseases. Numerous studies have highlighted the therapeutic potential of specific bacteria in preventing and treating metabolic, gastrointestinal and other diseases. Today, Chr. Hansen and Caelus Health announce their collaboration on the development of Eubacterium hallii as a next generation probiotic for prevention and treatment of metabolic disease.
